Comparable stake leader
BlackRock, Inc.
SEC ownership of CLOROX CO /DE/
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000021076.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
01 Apr 2026
- Public ticker
- CLX on NYSE
- Parsed ownership sources
- 13D/G, 13F, and 3/4/5
- Largest SEC-reported holder
- BlackRock, Inc.
- Latest 13D/G holder
- BlackRock, Inc.
- Latest parsed ownership date
- 01 Apr 2026
- Issuer CIK
- 0000021076
- Issuer location
- Oakland, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of CLOROX CO /DE/ (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
01 Apr 2026
13D/G
13F
3/4/5
Lead comparable stake: 8.1%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 8.1%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
8.1%
VANGUARD CAPITAL MANAGEMENT LLC
7.4%
UBS AM, a distinct business unit ...
0.9%
Linda J. Rendle
0.17%
Eric H. Reynolds
0.06%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
8.1%
|
$1,195,217,964
9,954,343 shares
|
-$205,050,863 | 30 Jun 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.4%
|
$921,224,274
8,889,552 shares
|
$0 | 31 Mar 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13D/G
13F
Company
|
0.9%
|
$148,823,364
1,081,801 shares
|
$0 | 31 Dec 2024 |
| Linda J. Rendle |
3/4/5
Chief Executive Officer, Director
|
0.17%
|
$20,685,385
201,161 shares
|
— | 12 Dec 2025 |
| Eric H. Reynolds |
3/4/5
EVP - Chief Operating Officer
|
0.06%
|
$7,101,234
69,058 shares
|
-$1,861,847 | 12 Dec 2025 |
| Kirsten Marriner |
3/4/5
EVP - Chief Admin Officer
|
0.03%
|
$3,904,455
37,970 shares
|
— | 12 Dec 2025 |
| Hyder Chris T. |
3/4/5
EVP-Group Pres -Hlth & Hyg
|
0.03%
|
$4,322,168
34,969 shares
|
— | 13 Mar 2026 |
| Stacey Grier |
3/4/5
EVP - Executive Chief of Staff
|
0.03%
|
$3,969,537
32,116 shares
|
— | 13 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$1,016,207.
Buys
$845,640
Insiders: 1
Sells
$1,861,847
Insiders: 1
Net
-$1,016,207
Shares: -6,041
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 9,000
Shares: 15,041
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 5,000 | 0 | $429,124 | $0 | +$429,124 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 4,000 | 0 | $416,516 | $0 | +$416,516 |
| 9-12 | 0 | 15,041 | $0 | $1,861,847 | -$1,861,847 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 36 reporting-owner rows connected to CLOROX CO /DE/. Open a relationship link for the CIK-to-CIK filing trail.
Rows
36
Largest Forms 3/4/5 holder
Linda J. Rendle
Net 12M change
-$1,016,207
Latest report
05 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Linda J. Rendle | Chief Executive Officer, Director | $20,685,385 | Mixed | 12 Dec 2025 | ||
| Kevin B. Jacobsen | EVP - Chief Financial Officer | $8,679,359 | Mixed | 19 Dec 2024 | ||
| Eric H. Reynolds | EVP - Chief Operating Officer | $7,101,234 | -$1,861,847 | -21% | Mixed | 12 Dec 2025 |
| Hyder Chris T. | EVP-Group Pres -Hlth & Hyg | $4,322,168 | Mixed | 13 Mar 2026 | ||
| Stacey Grier | EVP - Executive Chief of Staff | $3,969,537 | Mixed | 13 Mar 2026 | ||
| Kirsten Marriner | EVP - Chief Admin Officer | $3,904,455 | Mixed | 12 Dec 2025 | ||
| Richard H. Carmona | Director | $3,477,614 | Mixed | 31 Dec 2021 | ||
| Nina Barton | EVP-Group Pres-Care & Conn | $3,410,163 | Mixed | 03 Oct 2025 | ||
| Angela C. Hilt | EVP - Chief Legal Officer | $3,127,398 | Mixed | 12 Dec 2025 | ||
| Christopher J. Williams | Director | $2,737,731 | Mixed | 31 Mar 2026 | ||
| Rebecca Dunphey | SVP & GM - Specialty Division | $2,662,583 | Mixed | 21 Mar 2022 | ||
| Spencer C. Fleischer | Director | $2,643,528 | Mixed | 31 Dec 2025 | ||
| Matthew J. Shattock | Director | $2,338,154 | Mixed | 31 Mar 2026 | ||
| Esther Lee | Director | $2,192,378 | Mixed | 31 Dec 2025 | ||
| Russell J. Weiner | Director | $2,141,751 | Mixed | 31 Mar 2026 | ||
| Luc Bellet | EVP - Chief Financial Officer | $2,080,929 | Mixed | 01 Apr 2026 | ||
| Denise Garner | SVP - Chief Innovation Officer | $1,876,199 | Mixed | 20 Dec 2021 | ||
| Pierre R. Breber | Director | $1,581,975 | +$845,640 | +115% | Mixed | 05 May 2026 |
| A. D. David Mackay | Director | $1,476,697 | Mixed | 31 Dec 2025 | ||
| Diego J. Barral | SVP - GM, International | $1,458,981 | Mixed | 13 Sep 2022 |
Recent insider transactions for CLOROX CO /DE/
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Pierre R. Breber | CLX | Common Stock | Purchase | 38.5% | $429,124 | $85.82 | 5,000 | 18,000 | 05 May 2026 | By Trust |
| Luc Bellet | CLX | Common Stock | Tax liability | -1.17% | -244 | 20,638 | 01 Apr 2026 | Direct | ||
| Christopher J. Williams | CLX | Deferred Stock Units | Award | 1.22% | 265 | 22,075 | 31 Mar 2026 | Direct | ||
| Russell J. Weiner | CLX | Deferred Stock Units | Award | 1.84% | 326 | 18,004 | 31 Mar 2026 | Direct | ||
| Matthew J. Shattock | CLX | Deferred Stock Units | Award | 2.58% | 507 | 20,126 | 31 Mar 2026 | Direct | ||
| Pierre R. Breber | CLX | Deferred Stock Units | Award | 11.7% | 326 | 3,100 | 31 Mar 2026 | Direct | ||
| Stephanie Plaines | CLX | Deferred Stock Units | Award | 3.56% | 265 | 7,725 | 31 Mar 2026 | Direct | ||
| Hyder Chris T. | CLX | Common Stock | Tax liability | -0.12% | -41 | 34,969 | 13 Mar 2026 | Direct | ||
| Stacey Grier | CLX | Common Stock | Tax liability | -0.1% | -32 | 32,116 | 13 Mar 2026 | Direct | ||
| Christopher J. Williams | CLX | Deferred Stock Units | Award | 0.98% | 213 | 21,809 | 13 Feb 2026 | Direct | ||
| Russell J. Weiner | CLX | Deferred Stock Units | Award | 0.98% | 172 | 17,678 | 13 Feb 2026 | Direct | ||
| Matthew J. Shattock | CLX | Deferred Stock Units | Award | 0.98% | 191 | 19,620 | 13 Feb 2026 | Direct | ||
| Pierre R. Breber | CLX | Deferred Stock Units | Award | 0.98% | 27.05 | 2,774 | 13 Feb 2026 | Direct | ||
| Stephanie Plaines | CLX | Deferred Stock Units | Award | 0.98% | 72.73 | 7,460 | 13 Feb 2026 | Direct | ||
| Christopher J. Williams | CLX | Deferred Stock Units | Award | 9.71% | 1,911 | 21,597 | 31 Dec 2025 | Direct | ||
| Russell J. Weiner | CLX | Deferred Stock Units | Award | 12.7% | 1,973 | 17,506 | 31 Dec 2025 | Direct | ||
| Matthew J. Shattock | CLX | Deferred Stock Units | Award | 12.5% | 2,159 | 19,428 | 31 Dec 2025 | Direct | ||
| Stephanie Plaines | CLX | Deferred Stock Units | Award | 34.9% | 1,911 | 7,387 | 31 Dec 2025 | Direct | ||
| A. D. David Mackay | CLX | Deferred Stock Units | Award | 17.3% | 1,638 | 11,094 | 31 Dec 2025 | Direct | ||
| Esther Lee | CLX | Deferred Stock Units | Award | 11.7% | 1,638 | 15,677 | 31 Dec 2025 | Direct | ||
| Spencer C. Fleischer | CLX | Deferred Stock Units | Award | 7.17% | 1,364 | 20,383 | 31 Dec 2025 | Direct | ||
| Julia Charter | CLX | Deferred Stock Units | Award | 57.8% | 1,638 | 4,472 | 31 Dec 2025 | Direct | ||
| Pierre R. Breber | CLX | Deferred Stock Units | Award | 254.6% | 1,973 | 2,747 | 31 Dec 2025 | Direct | ||
| Stephen B. Bratspies | CLX | Deferred Stock Units | Award | 1,638 | 1,638 | 31 Dec 2025 | Direct | |||
| Gina Boswell | CLX | Deferred Stock Units | Award | 825 | 825 | 31 Dec 2025 | Direct | |||
| Eric H. Reynolds | CLX | Common Stock | Tax liability | -0.37% | -255 | 69,058 | 12 Dec 2025 | Direct | ||
| Linda J. Rendle | CLX | Common Stock | Tax liability | -0.41% | -829 | 201,161 | 12 Dec 2025 | Direct | ||
| Laurene E. Peck | CLX | Common Stock | Tax liability | -0.34% | -24 | 6,968 | 12 Dec 2025 | Direct | ||
| Kirsten Marriner | CLX | Common Stock | Tax liability | -0.81% | -310 | 37,970 | 12 Dec 2025 | Direct | ||
| Hyder Chris T. | CLX | Common Stock | Tax liability | -0.38% | -133 | 35,000 | 12 Dec 2025 | Direct | ||
| Stacey Grier | CLX | Common Stock | Tax liability | -0.2% | -65 | 32,138 | 12 Dec 2025 | Direct | ||
| Angela C. Hilt | CLX | Common Stock | Tax liability | -1.15% | -347 | 29,787 | 12 Dec 2025 | Direct | ||
| Pierre R. Breber | CLX | Common Stock | Purchase | 44.4% | $416,516 | $104.13 | 4,000 | 13,000 | 21 Nov 2025 | By Trust |
| Christopher J. Williams | CLX | Deferred Stock Units | Award | 1.17% | 227 | 19,686 | 06 Nov 2025 | Direct | ||
| Russell J. Weiner | CLX | Deferred Stock Units | Award | 1.17% | 179 | 15,533 | 06 Nov 2025 | Direct | ||
| Matthew J. Shattock | CLX | Deferred Stock Units | Award | 1.17% | 199 | 17,270 | 06 Nov 2025 | Direct | ||
| Stephanie Plaines | CLX | Deferred Stock Units | Award | 1.17% | 63.16 | 5,476 | 06 Nov 2025 | Direct | ||
| A. D. David Mackay | CLX | Deferred Stock Units | Award | 1.17% | 109 | 9,456 | 06 Nov 2025 | Direct | ||
| Esther Lee | CLX | Deferred Stock Units | Award | 1.17% | 162 | 14,040 | 06 Nov 2025 | Direct | ||
| Spencer C. Fleischer | CLX | Deferred Stock Units | Award | 1.17% | 219 | 19,019 | 06 Nov 2025 | Direct | ||
| Julia Charter | CLX | Deferred Stock Units | Award | 1.17% | 32.69 | 2,834 | 06 Nov 2025 | Direct | ||
| Pierre R. Breber | CLX | Deferred Stock Units | Award | 1.17% | 8.94 | 775 | 06 Nov 2025 | Direct | ||
| Linda J. Rendle | CLX | Common Stock | Tax liability | -4.47% | -9,462 | 201,990 | 03 Oct 2025 | Direct | ||
| Linda J. Rendle | CLX | Common Stock | Award | 25.8% | 43,370 | 211,452 | 03 Oct 2025 | Direct | ||
| Laurene E. Peck | CLX | Common Stock | Tax liability | -3.84% | -279 | 6,992 | 03 Oct 2025 | Direct | ||
| Laurene E. Peck | CLX | Common Stock | Award | 24.2% | 1,418 | 7,271 | 03 Oct 2025 | Direct | ||
| Hyder Chris T. | CLX | Common Stock | Tax liability | -3.06% | -1,110 | 35,133 | 03 Oct 2025 | Direct | ||
| Hyder Chris T. | CLX | Common Stock | Award | 23.2% | 6,812 | 36,243 | 03 Oct 2025 | Direct | ||
| Stacey Grier | CLX | Common Stock | Tax liability | -3.11% | -1,032 | 32,203 | 03 Oct 2025 | Direct | ||
| Stacey Grier | CLX | Common Stock | Award | 42.5% | 9,913 | 33,235 | 03 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.